Clinical Trials Directory

Trials / Completed

CompletedNCT05194748

Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease

Correlation of Diaphragmatic Thickness With Pulmonary Function in Parkinson's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Abant Izzet Baysal University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers

Summary

Ultrasound can give important information about the morphology of the diaphragm and the amount of contraction. Our aim, with the prediction that a restrictive pathology will occur in the pulmonary function with the addition of camptocormia in Parkinson's patients; to compare respiratory functions in Parkinson's patients with and without camptocormia, to investigate the correlation between ultrasonographically measured diaphragmatic thickness and pulmonary function test values.

Detailed description

Respiratory complications are one of the most common causes of death in Parkinson's patients. In Parkinson's disease, abnormal flexion of the thoracolumbar spine of 45° or more, which is called camptocormia, increases during walking or standing and disappears completely in the supine position. The prevalence of camptocormia among Parkinson's patients is about 7%. Camptocormia in Parkinson's disease is associated with significant disease disability, higher daily dopaminergic drug dosage, and cognitive impairment. Parkinson's patients with camptocormia often complain of shortness of breath, attributed to reduced pulmonary capacity due to limited chest expansion. Diaphragmatic dyskinesia in Parkinson's patients may also lead to a restrictive deterioration in respiratory functions. Diaphragmatic thickness indicates diaphragmatic contraction and is correlated with PFT. Our aim; It is a comparison of respiratory functions in Parkinson's patients with and without camptocormia.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention, observational onlyNo intervention, observational only

Timeline

Start date
2021-12-24
Primary completion
2023-01-01
Completion
2023-02-15
First posted
2022-01-18
Last updated
2024-04-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05194748. Inclusion in this directory is not an endorsement.